Emerging evidence show that TLR-4/NF-kappaB pathway is involved in ALI and the modulation of drugs for this pathway inhibits inflammation and apoptosis in improving ALI [14–16]. The gene discussed is TLR4; the disease is acute respiratory distress syndrome.